The Health Research Authority (HRA) protects and promotes the interests of patients and the public in health research. HRA is an executive non-departmental public body, sponsored by the Department of Health and Social Care.

The role plays an important part in protecting the rights, safety, dignity and well-being of research participants, while facilitating and promoting ethical research for the benefit of society. As leader of the committee, Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research, and clear decisions are made and recorded.

Keith Berelowitz said of the appointment:

“Ethics committees and the roles they perform in safeguarding patients involved in research are a vital part of our industry. I joined an ethics committee to give a little back and to expand my knowledge of academic and commercial clinical research, so, for me to take on this role as Chair for the Fulham Research Ethics Committee is an opportunity to continue that journey.”

We would like to take the opportunity to congratulate Keith on his appointment to the role of Committee Chair. His experience, knowledge and passion for patient safety and clinical trial operations will be invaluable to the Health Research Authority’s strategy for health across the UK.

Latest news

Von Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

First patient enrolled in telehealth study, the Pathway Study

February 25, 2025
The Pathway study is based on pioneering work during the pandemic between clinicians at Richmond Pharmacology and the National Amyloidosis Centre and aims...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event